Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDr. Martens Regulatory News (DOCS)

Share Price Information for Dr. Martens (DOCS)

Share Price is delayed by 15 minutes
Get Live Data
71.70    -0.30 (-0.42%)
Bid:
71.90
Ask:
72.10
Spread: 0.20 (0.278%)
Market Cap: £686.23m
DOCS Live PriceLast checked at - London Stock Exchange

Intraday Dr. Martens Share Chart

Directorate Change

24 Mar 2023 07:00

RNS Number : 0822U
Dr. Martens PLC
24 March 2023
 

Dr. Martens plc

APPOINTMENT OF NON-EXECUTIVE DIRECTOR

 

Dr. Martens plc ('the Company') today announces that, following a comprehensive search and selection process, Andrew Harrison will join the Board as an Independent Non-Executive Director with effect from 1 May 2023.

 

Andrew is a managing partner at consumer brand investment firm Freston Ventures and Senior Independent Director at Ocado Group plc, proprietor of the Ocado Smart Platform and joint owner of online grocer Ocado Retail Limited, where he is also chair of the Remuneration Committee and designated Non-Executive Director for engagement with the workforce. He built his executive career over more than two decades at Carphone Warehouse, where he served as Chief Executive and Chair. As a member of the early founding team, he drove the growth and international expansion of Carphone Warehouse from a small, privately owned retailer to established market leader and FTSE constituent, subsequently leading the merger of the business with Dixons in 2014, where he was Deputy Chief Executive.

 

Paul Mason, Chairman, said:

 

"I am delighted to welcome Andrew to the Dr. Martens Board. He brings a wealth of expertise of consumer facing and technology focused businesses and a highly entrepreneurial mindset. His significant prior experience as both a Chief Executive and Non-Executive Director of large, listed companies will bolster the Board and will be invaluable to the business as we embark on the next chapter of the Dr. Martens story."

 

On joining the Board, Andrew will also become a member of the Audit, Remuneration and Nomination Committees.

 

The Company confirms that there is no further information required to be disclosed pursuant to paragraph 9.6.13 of the UK Listing Rules.

 

 

Enquiries

 

Investors and analysts

Mark Blythman, Interim Director of Investor Relations +44 7570 871207

mark.blythman@drmartens.com

Media

Gill Hammond, Director of Communications +44 7384 214248

 

H/Advisors Maitland

Rhys Jones +44 7881 996460

 

About Dr. Martens

Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical movements. Dr. Martens has since transcended its working-class roots while still celebrating its proud heritage and, six decades later, "Docs" or "DMs" are worn by people around the world who use them as a symbol of empowerment and their own individual attitude. 

 

The Company listed successfully on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and is a constituent of the FTSE 250 index.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOASEAFUDEDSEED
Date   Source Headline
14th Jul 20237:00 amRNSCommencement of Share Buyback Programme
13th Jul 202312:24 pmRNSResult of AGM
13th Jul 20237:00 amRNSTrading Statement
12th Jul 20233:59 pmRNSDirector/PDMR Shareholding
11th Jul 20231:59 pmRNSHolding(s) in Company
4th Jul 20239:12 amRNSTotal Voting Rights
4th Jul 20239:00 amRNSDirector/PDMR Shareholding
13th Jun 20231:09 pmRNSDirector/PDMR Shareholding
13th Jun 20239:00 amRNSAnnual Financial Report
7th Jun 20234:37 pmRNSNotification of transaction of PCA of PDMR
5th Jun 20234:49 pmRNSDirector/PDMR Shareholding
5th Jun 20233:00 pmRNSDirector/PDMR Shareholding
1st Jun 202312:03 pmRNSBlock listing Interim Review
1st Jun 202311:00 amRNSTotal Voting Rights
1st Jun 20237:00 amRNSFinal Results
17th May 202311:30 amRNSDirector/PDMR Shareholding
2nd May 20233:12 pmRNSTotal Voting Rights
17th Apr 20237:00 amRNSDirector/PDMR Shareholding
14th Apr 20237:01 amRNSCFO retirement
14th Apr 20237:00 amRNSTrading Statement
3rd Apr 20232:54 pmRNSTotal Voting Rights
24th Mar 20237:00 amRNSDirectorate Change
14th Mar 20235:09 pmRNSReplacement Director/PDMR Shareholding
14th Mar 20233:19 pmRNSDirector/PDMR Shareholding
1st Mar 20234:17 pmRNSTotal Voting Rights
15th Feb 20232:16 pmRNSDirector/PDMR Shareholding
6th Feb 20235:30 pmRNSDirector/PDMR Shareholding
1st Feb 202312:12 pmRNSTotal Voting Rights
19th Jan 20237:00 amRNSTrading Statement
13th Jan 20232:11 pmRNSDirector/PDMR Shareholding
3rd Jan 20233:36 pmRNSTotal Voting Rights
14th Dec 20221:35 pmRNSDirector/PDMR Shareholding
1st Dec 20228:38 amRNSTotal Voting Rights
30th Nov 202210:02 amRNSDirector/PDMR Shareholding
24th Nov 20227:00 amRNSHalf-year Report
15th Nov 20223:54 pmRNSBlock listing Interim Review
15th Nov 20223:44 pmRNSDirector/PDMR Shareholding
1st Nov 20227:00 amRNSTotal Voting Rights
1st Sep 20227:00 amRNSTotal Voting Rights
23rd Aug 20222:38 pmRNSDirector/PDMR Shareholding
1st Aug 202211:51 amRNSTotal Voting Rights
14th Jul 202212:33 pmRNSResult of AGM
14th Jul 20227:00 amRNSTrading Statement
6th Jul 20227:00 amRNSConversion Markets - teach-in event
29th Jun 20228:13 amRNSDirector Declaration
16th Jun 202212:16 pmRNSDirector/PDMR Shareholding
14th Jun 20229:00 amRNSAnnual Financial Report
1st Jun 20227:00 amRNSFinal Results
27th Apr 20228:57 amRNSDirector Declaration
1st Apr 20223:18 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.